Cira^TMImmunoassay platform utilizing the patent of rount ciraplex dot matrix, in combinaiton with ELISA of high acurarcy and precision, chemiluminescence detection of high sensitivity, and high throughput multi-biomarker profiling system, provide researchers with humanized service of accurate multi-factor biomarker detections.